A staged screening of registered drugs highlights remyelinating drug candidates for clinical trials
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A staged screening of registered drugs highlights remyelinating drug candidates for clinical trials
Authors
Keywords
-
Journal
Scientific Reports
Volume 7, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-04-07
DOI
10.1038/srep45780
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Restoration of Visual Function by Enhancing Conduction in Regenerated Axons
- (2016) Fengfeng Bei et al. CELL
- Repair strategies for multiple sclerosis
- (2016) Bruno Stankoff et al. CURRENT OPINION IN NEUROLOGY
- Development of a novel oral delivery system of edaravone for enhancing bioavailability
- (2016) Ankit Parikh et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Can you teach old drugs new tricks?
- (2016) Nicola Nosengo NATURE
- Fingolimod failure in progressive MS INFORMS future trials
- (2016) Andrew L. Smith et al. Nature Reviews Neurology
- HMG-CoA Reductase Inhibitors Bind to PPARα to Upregulate Neurotrophin Expression in the Brain and Improve Memory in Mice
- (2015) Avik Roy et al. Cell Metabolism
- A much-needed focus on progression in multiple sclerosis
- (2015) Alan J Thompson LANCET NEUROLOGY
- Riluzole in patients with hereditary cerebellar ataxia: a randomised, double-blind, placebo-controlled trial
- (2015) Silvia Romano et al. LANCET NEUROLOGY
- Progressive MS: from pathophysiology to drug discovery
- (2015) Marco Salvetti et al. Multiple Sclerosis Journal
- Drug-based modulation of endogenous stem cells promotes functional remyelination in vivo
- (2015) Fadi J. Najm et al. NATURE
- Fingolimod treatment promotes proliferation and differentiation of oligodendrocyte progenitor cells in mice with experimental autoimmune encephalomyelitis
- (2015) Jing Zhang et al. NEUROBIOLOGY OF DISEASE
- Edaravone alleviates Alzheimer’s disease-type pathologies and cognitive deficits
- (2015) Shu-Sheng Jiao et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Progressive MS: from pathophysiology to drug discovery
- (2015) Marco Salvetti et al. Multiple Sclerosis Journal
- The problem with repurposing: Is there really an alternative to Big Pharma for developing new drugs for multiple sclerosis?
- (2015) Gavin Giovannoni et al. Multiple Sclerosis and Related Disorders
- Remyelination Therapy in Multiple Sclerosis
- (2015) Danielle E. Harlow et al. Frontiers in Neurology
- Anti-inflammatory effects of Edaravone and Scutellarin in activated microglia in experimentally induced ischemia injury in rats and in BV-2 microglia
- (2014) Yun Yuan et al. BMC NEUROSCIENCE
- Pivotal role of choline metabolites in remyelination
- (2014) Thomas Skripuletz et al. BRAIN
- Does GRK–β arrestin machinery work as a “switch on” for GPR17-mediated activation of intracellular signaling pathways?
- (2014) Simona Daniele et al. CELLULAR SIGNALLING
- Effect of high-dose simvastatin on brain atrophy and disability in secondary progressive multiple sclerosis (MS-STAT): a randomised, placebo-controlled, phase 2 trial
- (2014) Jeremy Chataway et al. LANCET
- Confirmatory double-blind, parallel-group, placebo-controlled study of efficacy and safety of edaravone (MCI-186) in amyotrophic lateral sclerosis patients
- (2014) Koji Abe et al. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
- Targeting ASIC1 in primary progressive multiple sclerosis: evidence of neuroprotection with amiloride
- (2013) Tarunya Arun et al. BRAIN
- Computational Drug Repositioning: From Data to Therapeutics
- (2013) M R Hurle et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Inhibition of phosphodiesterase-4 promotes oligodendrocyte precursor cell differentiation and enhances CNS remyelination
- (2013) Yasir A. Syed et al. EMBO Molecular Medicine
- Edaravone Improves Functional and Structural Outcomes in Animal Models of Focal Cerebral Ischemia: A Systematic Review
- (2013) Simiao Wu et al. International Journal of Stroke
- Hydroxypropyl-Sulfobutyl-β-Cyclodextrin Improves the Oral Bioavailability of Edaravone by Modulating Drug Efflux Pump of Enterocytes
- (2013) Wen-Ting Rong et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- A regenerative approach to the treatment of multiple sclerosis
- (2013) Vishal A. Deshmukh et al. NATURE
- Effects of Bacille Calmette-Guerin after the first demyelinating event in the CNS
- (2013) G. Ristori et al. NEUROLOGY
- Contribution of Genome-Wide Association Studies to Scientific Research: A Pragmatic Approach to Evaluate Their Impact
- (2013) Vito A. G. Ricigliano et al. PLoS One
- Oxidative Stress Interferes With White Matter Renewal After Prolonged Cerebral Hypoperfusion in Mice
- (2013) Nobukazu Miyamoto et al. STROKE
- Exogenous Leukemia Inhibitory Factor Stimulates Oligodendrocyte Progenitor Cell Proliferation and Enhances Hippocampal Remyelination
- (2012) B. E. Deverman et al. JOURNAL OF NEUROSCIENCE
- The NIH's role in accelerating translational sciences
- (2012) John C Reed et al. NATURE BIOTECHNOLOGY
- Progesterone and Nestorone Facilitate Axon Remyelination: A Role for Progesterone Receptors
- (2011) Rashad Hussain et al. ENDOCRINOLOGY
- Central nervous system remyelination in culture — A tool for multiple sclerosis research
- (2011) Hui Zhang et al. EXPERIMENTAL NEUROLOGY
- Axon-glia synapses are highly vulnerable to white matter injury in the developing brain
- (2011) Yan Shen et al. JOURNAL OF NEUROSCIENCE RESEARCH
- Nonprofit disease groups earmark grants for drug repositioning
- (2011) Elie Dolgin NATURE MEDICINE
- Activation of PPAR-γ and PTEN cascade participates in lovastatin-mediated accelerated differentiation of oligodendrocyte progenitor cells
- (2010) Ajaib S. Paintlia et al. GLIA
- Riluzole in cerebellar ataxia: A randomized, double-blind, placebo-controlled pilot trial
- (2010) G. Ristori et al. NEUROLOGY
- Ibudilast in relapsing-remitting multiple sclerosis: A neuroprotectant?
- (2010) F. Barkhof et al. NEUROLOGY
- Further studies on the pharmacological profile of the neuropeptide S receptor antagonist SHA 68
- (2010) Chiara Ruzza et al. PEPTIDES
- A Novel Administration Route of Edaravone – II: Mucosal Absorption of Edaravone from Edaravone/Hydroxypropyl-Beta-Cyclodextrin Complex Solution Including L-Cysteine and Sodium Hydrogen Sulfite
- (2010) Toshiaki Sato et al. PHARMACOLOGY
- Edaravone, a free radical scavenger, protects components of the neurovascular unit against oxidative stress in vitro
- (2009) Brian J. Lee et al. BRAIN RESEARCH
- Neuroprotective effects of edaravone-administration on 6-OHDA-treated dopaminergic neurons
- (2008) Wen Ji Yuan et al. BMC NEUROSCIENCE
- Inhibition of Rho Family Functions by Lovastatin Promotes Myelin Repair in Ameliorating Experimental Autoimmune Encephalomyelitis
- (2008) A. S. Paintlia et al. MOLECULAR PHARMACOLOGY
- Remyelination in the CNS: from biology to therapy
- (2008) Robin J. M. Franklin et al. NATURE REVIEWS NEUROSCIENCE
- Edaravone, a free radical scavenger, ameliorates experimental autoimmune encephalomyelitis
- (2008) Masayuki Moriya et al. NEUROSCIENCE LETTERS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started